Significantly, over 70% of human breast cancers express NIS, raising the prospect of the possible use of radioiodide in the diagnosis and treatment of breast cancer[6], as is routinely and successfully done in the treatment of NIS-expressing thyroid cancer. This evidence concerns the gene SLC5A5 and breast carcinoma.